Clinical Trial Update: A Dose Finding Study To Evaluate Safety, Drug Interaction, Tumor Markers Of Axitinib In Combination With MK-3475 In Adult Patients With Previously Untreated Advanced Renal Cell Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial updating safety, drug interaction, and tumor marker data for axitinib in combination with MK-3475 in adults with previously untreated advanced ren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Axitinib (Axitinib)
• MK-3475 (pembrolizumab)

Snippet

Sponsor: Pfizer | Conditions: Renal Cell Carcinoma | Phase 1 | Status: COMPLETED | Results posted: 2019-06-21